Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HOXB4 is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. Additionally we are shipping Homeobox B4 Proteins (7) and Homeobox B4 Kits (2) and many more products for this protein.
Showing 10 out of 95 products:
Human Polyclonal HOXB4 Primary Antibody for ELISA - ABIN449842
Chan, Bonde, Klump, Zavazava: Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. in Blood 2008
the similarity of hoxb3a/Hoxa3 (show HOXA3 Antibodies) regulatory mechanisms reflect the shared descent of both genes from a single ancestral paralog, expression of both genes in the posterior hindbrain and spinal cord in embryo
HOXB4 knockout led to downregulation of P-glycoprotein, multidrug resistance-associated protein 1 (show ABCC1 Antibodies) and breast cancer resistance protein (show ABCG2 Antibodies) expression and PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) signaling activity, suggesting that repression of HOXB4 might be a key point to reverse Multidrug resistance of K562/ADM (show ADM Antibodies) cells.
This study provides novel evidences of the mechanisms integrating Notch (show NOTCH1 Antibodies) and TNF-alpha (show TNF Antibodies) signaling in the transcriptional induction of GATA3 (show GATA3 Antibodies) and HOXB4.
Increased expression of HOXB4 in human embryonic stem cells enhances the production of hematopoietic Progenitors but does not effect the maturation of red blood cells.
The analysis of HOX (show MSH2 Antibodies) expression in primary mesothelioma tumors indicated that these cells could also be sensitive to the disruption of HOX (show MSH2 Antibodies) activity by HXR9, and that the expression of HOXB4 is strongly associated with overall survival
HOXA4 (show HOXA4 Antibodies) increases short-term repopulation to higher levels than HOXB4, which may involve Notch (show NOTCH1 Antibodies) signaling to induce self-renewal of primitive hematopoietic cells
showed that OAC1 treatment led to OCT4 (show POU5F1 Antibodies)-mediated upregulation of HOXB4
decreased methylation at HOXB3 (show HOXB3 Antibodies) and HOXB4 was associated with increased gene expression of both HOXB genes specific to the mid-risk AML (show RUNX1 Antibodies), while increased DNA methylation (show HELLS Antibodies) at DCC (show DCC Antibodies) distinctive to the high-risk AML (show RUNX1 Antibodies) was associated with increased gene expression
Epigenetic analysis revealed that increased promoter methylation of HOXB4 correlates with decreased expression of its transcript in oral cancer cell lines. HOXB4 may work as an epigenetic biomarker gene.
Our study demonstrates for the first time the regulation of HOXB4 by miR (show MLXIP Antibodies)-23a
our results outline the effects of HOXB4 in combination with stromal cells in the development of NK cells from embryonic stem cells.
can amplify long-term repopulating hematopoietic stem cells in a controlled way. This characteristic depends on a proline-rich sequence near the N terminus, which is unique among HOX (show MSH2 Antibodies) genes and highly conserved in higher mammals
Data suggest that the homeobox B4 protein (HoxB4) and signal transducer and activator of transcription 3 (STAT3 (show STAT3 Antibodies)) signals are functionally redundant for hematopoietic stem cells (HSCs) self-renewal rather than exerting independent effects.
these studies define the transcriptional pathways involved in HOXB4 HSC (show FUT1 Antibodies) expansion in vivo and identify repression of Prdm16 (show PRDM16 Antibodies) transcription as a mechanism by which expanding HSCs avoid leukemic transformation.
Hoxb4 favours the maintenance and increase of the CD4 (show CD4 Antibodies) central memory phenotype T cell population.
The results show a novel role for DNA methylation (show HELLS Antibodies) in the alternative promoter usage at the Runx1 (show RUNX1 Antibodies) locus and identify HOXB4 as a direct activator of the Runx1 (show RUNX1 Antibodies) P1 promoter.
Loss of Scmh1 (show SCMH1 Antibodies) caused derepression of Hoxb4 and Hoxa9 (show HOXA9 Antibodies), direct targets of Polycomb (show CBX2 Antibodies)-group complex 1-mediated transcriptional silencing in hematopoietic cells.
HOXB4 activation can generate a paracrine as well as a cell autonomous effect on hematopoietic differentiation.
HoxB4 reprograms a set of key regulator genes to facilitate the maturation of developing hematopoietic stem cells into repopulating cells
Hoxb4 expression therefore would not appear to correlate with the cycling status of fetal liver hematopoietic stem cells(HSCs), although highly proliferative HSCs from young BM show strong Hoxb4 expression.
Data suggest that transduced Hoxb4 down-regulates Geminin protein (show GMNN Antibodies) probably by constituting the E3 ubiquitin ligase (show MUL1 Antibodies) for Geminin (show GMNN Antibodies) to provide hematopoietic stem and progenitor cells with proliferation potential.
This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Intracellular or ectopic expression of this protein expands hematopoietic stem and progenitor cells in vivo and in vitro, making it a potential candidate for therapeutic stem cell expansion.
, homeo box B4
, hox4 protein
, hoxb4a protein
, Hoxb4a variant 2
, homeobox gene B-4
, homeobox protein Hox-B4a
, homeobox protein Zf-13
, homeo box 2F
, homeobox protein Hox-2.6
, homeobox protein Hox-2F
, homeobox protein Hox-B4
, homeobox protein Hox-Z